CN103816346A - Traditional Chinese medicine for hepatitis B virus (HBV) - Google Patents

Traditional Chinese medicine for hepatitis B virus (HBV) Download PDF

Info

Publication number
CN103816346A
CN103816346A CN201210484875.4A CN201210484875A CN103816346A CN 103816346 A CN103816346 A CN 103816346A CN 201210484875 A CN201210484875 A CN 201210484875A CN 103816346 A CN103816346 A CN 103816346A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
hepatitis
hbv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210484875.4A
Other languages
Chinese (zh)
Inventor
丁徽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210484875.4A priority Critical patent/CN103816346A/en
Publication of CN103816346A publication Critical patent/CN103816346A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for hepatitis B virus (HBV). The traditional Chinese medicine for HBV comprises the following raw materials by weight: 15 to 30 parts of polygonum cuspidatum, 15 parts of manyleaf paris rhizome, 30 parts of hedyotis diffusa, 15 parts of phyllanthus amarus, 15 parts of radix isatidis, 5 parts of nidus vespae, 15 parts of red paeonia, 30 parts of salvia miltiorrhiza, 30 parts of astragali radix, 15 parts of radix polygoni multiflori preparata, and 15 parts of morinda officinalis. The traditional Chinese medicine for HBV provided by the invention has the effects of clearing away heat and toxic materials, promoting blood circulation to dissolve blood stasis, clearing damp and removing jaundice.

Description

A kind of Chinese medicine for hepatitis B
Technical field
The present invention relates to a kind of Chinese medicine for hepatitis B.
Background technology
The Western medicine of hepatitis B virus antiviral is very common clinically, but because the side effect of Western medicine antiviral is large, thus a lot of patient all upon the look medicine carry out antiviral therapy.The medicine of current treatment hepatitis B has many, and a lot of hepatitis B patients use western medical treatment hepatitis B but effect is general, have taken a large amount of antiviral agents, and costly but disease is not cured, and easily has side effects.The Chinese crude drugs such as Rhizoma Dioscoreae in Chinese crude drug, Poria, Radix Angelicae Sinensis, the Radix Astragali, Radix Ginseng, Radix Et Caulis Acanthopanacis Senticosi, Radix Codonopsis, Fructus Corni, Radix Polygoni Multiflori, Ganoderma are to help antiviral by improving patient's body immunity.Also be significant to the rehabilitation of hepatitis B patient.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of Chinese medicine for hepatitis B.
Technical scheme of the present invention is: a kind of Chinese medicine for hepatitis B, it is made up of the raw material of following parts by weight: Rhizoma Polygoni Cuspidati 15-30, Rhizoma Paridis 15, Herba Hedyotidis Diffusae 30, Phyllanthusamarus 15, Radix Isatidis 15, Nidus Vespae 5, Radix Paeoniae Rubra 15, Radix Salviae Miltiorrhizae 30, Radix Astragali 30, Radix Polygoni Multiflori Preparata 15, Radix Morindae Officinalis 15.
The present invention has effect of heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, damp eliminating jaundice eliminating.
Be decocted in water for oral dose, twice on the one.
The specific embodiment
For a Chinese medicine for hepatitis B, it is made up of the raw material of following parts by weight: Rhizoma Polygoni Cuspidati 15-30g, Rhizoma Paridis 15g, Herba Hedyotidis Diffusae 30g, Phyllanthusamarus 15g, Radix Isatidis 15g, Nidus Vespae 5g, Radix Paeoniae Rubra 15g, Radix Salviae Miltiorrhizae 30g, Radix Astragali 30g, Radix Polygoni Multiflori Preparata 15g, Radix Morindae Officinalis 15g.

Claims (1)

1. the Chinese medicine for hepatitis B, it is characterized in that, it is made up of the raw material of following parts by weight: Rhizoma Polygoni Cuspidati 15-30, Rhizoma Paridis 15, Herba Hedyotidis Diffusae 30, Phyllanthusamarus 15, Radix Isatidis 15, Nidus Vespae 5, Radix Paeoniae Rubra 15, Radix Salviae Miltiorrhizae 30, Radix Astragali 30, Radix Polygoni Multiflori Preparata 15, Radix Morindae Officinalis 15.
CN201210484875.4A 2012-11-16 2012-11-16 Traditional Chinese medicine for hepatitis B virus (HBV) Pending CN103816346A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210484875.4A CN103816346A (en) 2012-11-16 2012-11-16 Traditional Chinese medicine for hepatitis B virus (HBV)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210484875.4A CN103816346A (en) 2012-11-16 2012-11-16 Traditional Chinese medicine for hepatitis B virus (HBV)

Publications (1)

Publication Number Publication Date
CN103816346A true CN103816346A (en) 2014-05-28

Family

ID=50751826

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210484875.4A Pending CN103816346A (en) 2012-11-16 2012-11-16 Traditional Chinese medicine for hepatitis B virus (HBV)

Country Status (1)

Country Link
CN (1) CN103816346A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107296930A (en) * 2017-07-04 2017-10-27 广东宜众堂生物科技有限公司 Chinese medicine preparation for preventing and treating hepatopathy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679898A (en) * 2005-01-13 2005-10-12 刘桂香 Chinese medicine composition for treating hepatitis and cancers
CN1682814A (en) * 2005-02-23 2005-10-19 赵东科 Medicine for treating hepatitis B and its preparing method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679898A (en) * 2005-01-13 2005-10-12 刘桂香 Chinese medicine composition for treating hepatitis and cancers
CN1682814A (en) * 2005-02-23 2005-10-19 赵东科 Medicine for treating hepatitis B and its preparing method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
华何与等: "乙肝扶正排毒胶囊对实验性肝损伤的作用研究", 《中国中医基础医学杂志》, vol. 12, no. 05, 28 May 2006 (2006-05-28) *
张红栓: "乙肝扶正排毒胶囊体外抗乙肝病毒及对NF-kb活化干预的实验研究", 《中国优秀硕士学位论文全文数据库》, no. 01, 15 January 2007 (2007-01-15) *
张红栓等: "乙肝扶正排毒胶囊体外抗乙肝病毒及对NF-kb活化干预的实验研究", 《湖南中医杂志》, vol. 22, no. 03, 25 May 2006 (2006-05-25), pages 84 - 86 *
邵颖: "干扰素联合珍珠草乙肝舒康胶囊治疗慢性乙型肝炎临床研究", 《中国中医药信息杂志》, vol. 12, no. 04, 15 April 2005 (2005-04-15), pages 12 - 13 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107296930A (en) * 2017-07-04 2017-10-27 广东宜众堂生物科技有限公司 Chinese medicine preparation for preventing and treating hepatopathy

Similar Documents

Publication Publication Date Title
CN1124153C (en) Medicinal composition for restoring cardiac collaterals and its application
CN101129552A (en) Traditional Chinese medicine for treating chronic functional constipation
CN101259190A (en) Chinese medicine assembly for warming kidney, compensating spleen, benefitting qi and nourishing blood and preparation thereof
CN101167927A (en) Traditional Chinese medicine formula for treating eye and face spasm
CN102240377A (en) Formula of drug for treating rhinitis
CN103230548A (en) Traditional Chinese medicine composition for treating pulmonary heart disease
CN104337974A (en) Drug for treating metrorrhagia and preparation method thereof
CN1327889C (en) Chinese medicine for treating heart disease
CN101884761A (en) Medicament for treating cirrhosis and portal hypertension
CN103341133A (en) Traditional Chinese medicine composition for treating fatty liver and preparation method thereof
CN104547785A (en) Traditional Chinese medicine for treating hepatitis
CN1186687A (en) Cancer preventing curing medicine series and its preparation
CN101444613A (en) Traditional Chinese medicine formula for treating chronic hepatitis
CN102370877A (en) Traditional Chinese medicinal composition for treating endocrine dyscrasia
CN101862402A (en) Chinese medicament for treating liver diseases
CN101991747A (en) Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis
CN104707089A (en) Coronary heart disease treating traditional Chinese medicine formula
CN103816346A (en) Traditional Chinese medicine for hepatitis B virus (HBV)
CN103446535B (en) A kind of Miao Ethnomedicine for the treatment of coronary heart disease
CN101850072A (en) Chinese patent medicament for treating hepatitis B
CN103860876A (en) Essence liquid for treating hepatitis B
CN1332705C (en) Chinese medicine for treating liver diseases
CN103877369A (en) Hepatitis B treatment compound
CN102038834A (en) Traditional Chinese medicine preparation for preventing and treating cancers
CN103212024A (en) Chinese medicinal formula for treating dysmenorrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140528